Stay updated on EMPIRE CF: CTX-4430 Clinical Trial
Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. This appears to be a minor maintenance update with no visible changes to study details or navigation.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision: v3.3.1 appears on the page, replacing v3.2.0; this appears to be an internal site version update with no visible changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe government funding notice/banner was removed from the page, taking away information about potential updates or delays due to funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check33 days agoChange DetectedThe changes appear to be minor UI/layout updates to the Study Details page with no impact on core trial information such as eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check69 days agoChange DetectedUpdate to v3.1.0 with removal of several named drug-safety topics from the page, indicating a scope shift and version upgrade.SummaryDifference0.4%

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.